CME Stock Recent News

CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

I explore the idea of managing a highly concentrated portfolio and share how I narrowed down my highest-conviction dividend investments to just five stocks. I emphasize the importance of choosing reliable companies, future-proof wealth compounders, even in a compact portfolio with limited stock picks. After careful analysis, I present my top five dividend stocks, each chosen for their unique qualities, strong growth potential, and ability to thrive long-term.

The Fed surprised markets with a 50 basis point rate cut, signaling a focus on economic growth over inflation. Projections show rates falling to 3% in the coming years. Despite sticky inflation, the Fed's shift supports my long-term thesis: economic stability will be prioritized. This makes high-quality dividend stocks attractive investments. Dividend stocks with pricing power, like energy and royalty companies, offer inflation protection. Now is an ideal time to invest in these long-term income plays.

Intercontinental Exchange, CME Group, Nasdaq, Cboe Global and MarketAxess have been highlighted in this Industry Outlook article.

CHICAGO, Sept. 5, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that Chairman and Chief Executive Officer Terry Duffy will participate in a fireside chat at the 22nd Annual Barclays Global Financial Services Conference in New York on Monday, September 9, at 2:45 p.m. Eastern Time.

CHICAGO , Sept. 5, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch options on Bloomberg Commodity Index (BCOM) futures on September 23, pending regulatory review.

CHICAGO , Sept. 5, 2024 /PRNewswire/ -- CME Group Inc. will announce earnings for the third quarter of 2024 before the markets open on Wednesday, October 23, 2024.

BofA Securities analyst Craig Siegenthaler downgraded CME Group Inc CME to Underperform from Neutral, lowering the price target from $212 to $177.

CHICAGO , Sept. 3, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that open interest in its deeply liquid SOFR futures set a new record of 12,701,232 contracts on August 28, as the product's average daily volume (ADV) reached a record 3.5 million contracts year-to-date.

CME Group is a resilient and defensible business, with high margins and a great balance sheet. Interest rate derivatives, CME's highest volume segment, are poised for growth amid expected rate cuts, enhancing CME's revenue prospects. CME stock's valuation is cheaper than the S&P 500 and will likely offer safety in times of market turmoil.